These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18698041)

  • 1. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
    Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
    Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear and cytoplasmic expressions of ERβ1 and ERβ2 are predictive of response to therapy and alters prognosis in familial breast cancers.
    Yan M; Rayoo M; Takano EA; ; Fox SB
    Breast Cancer Res Treat; 2011 Apr; 126(2):395-405. PubMed ID: 20490651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of estrogen receptors β2, 5 identifies and is associated with prognosis in non-small cell lung cancer.
    Liu Z; Liao Y; Tang H; Chen G
    Endocrine; 2013 Oct; 44(2):517-24. PubMed ID: 23475473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy.
    Schade GR; Holt SK; Zhang X; Song D; Wright JL; Zhao S; Kolb S; Lam HM; Levin L; Leung YK; Ho SM; Stanford JL
    J Urol; 2016 Jun; 195(6):1760-6. PubMed ID: 26804755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer.
    Ciucci A; Zannoni GF; Travaglia D; Petrillo M; Scambia G; Gallo D
    Gynecol Oncol; 2014 Feb; 132(2):351-9. PubMed ID: 24378878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer.
    Davies MP; O'Neill PA; Innes H; Sibson DR; Prime W; Holcombe C; Foster CS
    J Mol Endocrinol; 2004 Dec; 33(3):773-82. PubMed ID: 15591034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion.
    Leung YK; Lam HM; Wu S; Song D; Levin L; Cheng L; Wu CL; Ho SM
    Endocr Relat Cancer; 2010 Sep; 17(3):675-89. PubMed ID: 20501637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.
    Chantzi NI; Tiniakos DG; Palaiologou M; Goutas N; Filippidis T; Vassilaros SD; Dhimolea E; Mitsiou DJ; Alexis MN
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1489-98. PubMed ID: 23817696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.
    Yan S; Dey P; Ziegler Y; Jiao X; Kim SH; Katzenellenbogen JA; Katzenellenbogen BS
    Breast Cancer Res Treat; 2021 Jan; 185(2):281-292. PubMed ID: 33001337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of estrogen receptor β2 in breast cancer.
    Baek JM; Chae BJ; Song BJ; Jung SS
    Int J Surg; 2015 Feb; 14():17-22. PubMed ID: 25450264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
    Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
    BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptors β1 and β2 are associated with distinct responses of estrogen receptor α-positive breast carcinoma to adjuvant endocrine therapy.
    Dhimolea E; Tiniakos DG; Chantzi ΝΙ; Goutas N; Vassilaros SD; Mitsiou DJ; Alexis ΜN
    Cancer Lett; 2015 Mar; 358(1):37-42. PubMed ID: 25524554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone receptor expression profile of low-grade serous ovarian cancers.
    Buttarelli M; Mascilini F; Zannoni GF; Ciucci A; Martinelli E; Filippetti F; Scambia G; Ferrandina G; Gallo D
    Gynecol Oncol; 2017 May; 145(2):352-360. PubMed ID: 28228232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†.
    Speirs V; Viale G; Mousa K; Palmieri C; Reed SN; Nicholas H; Cheang M; Jassem J; Lønning PE; Kalaitzaki E; van de Velde CJH; Rasmussen BB; Verhoeven DM; Shaaban AM; Bartlett JMS; Bliss JM; Coombes RC;
    Ann Oncol; 2015 Sep; 26(9):1890-1897. PubMed ID: 26002610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.
    Vinayagam R; Sibson DR; Holcombe C; Aachi V; Davies MP
    BMC Cancer; 2007 Jul; 7():131. PubMed ID: 17640362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer.
    Mandusic V; Dimitrijevic B; Nikolic-Vukosavljevic D; Neskovic-Konstantinovic Z; Kanjer K; Hamann U
    Cancer Lett; 2012 Aug; 321(1):73-9. PubMed ID: 22366496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.
    Wimberly H; Han G; Pinnaduwage D; Murphy LC; Yang XR; Andrulis IL; Sherman M; Figueroa J; Rimm DL
    Breast Cancer Res Treat; 2014 Aug; 146(3):657-67. PubMed ID: 25007965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid.
    Meligova AK; Siakouli D; Stasinopoulou S; Xenopoulou DS; Zoumpouli M; Ganou V; Gkotsi EF; Chatziioannou A; Papadodima O; Pilalis E; Alexis MN; Mitsiou DJ
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer.
    Mandusić V; Nikolić-Vukosavljević D; Tanić N; Kanjer K; Neskovic-Konstantinović Z; Celeketić D; Dimitrijević B
    J Cancer Res Clin Oncol; 2007 Aug; 133(8):571-9. PubMed ID: 17457609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.